Preliminary Results of a Phase 1, First-in-human Study of INA03, an Anti-Cd71 Antibody-Drug Conjugate, in Patients with Relapsed or Refractory (R/R) Acute Leukemias
BLOOD（2024）
Key words
Immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined